Exact Mass: 692.3718
Exact Mass Matches: 692.3718
Found 231 metabolites which its exact mass value is equals to given mass value 692.3718
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Scillaren A
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides
Pisumoside B
Pisumoside B is found in common pea. Pisumoside B is a constituent of Pisum sativum (pea). Constituent of Pisum sativum (pea). Pisumoside B is found in pulses and common pea.
Bismahanine
Bismahanine is found in herbs and spices. Bismahanine is an alkaloid from the stem bark of Murraya koenigii (curryleaf tree). Alkaloid from the stem bark of Murraya koenigii (curryleaf tree). Bismahanine is found in herbs and spices.
Opiorphin
Opiorphin is an endogenous 5-residue opioid peptide (Gln-Arg-Phe-Ser-Arg) first isolated from human saliva. Initial research with mice shows the compound has a painkilling effect greater than that of morphine. It works by stopping the normal breakdown of enkephalins, natural pain-killing opioids in the spinal cord. Opiorphin originates from the N-terminal region of the protein PROL1 (proline rich, lacrimal 1) and inhibits three proteases: neutral ecto-endopeptidase (MME), ecto-aminopeptidase N (ANPEP) and a dipeptidyl peptidase DPP3. This protease inhibitory action extends the duration of enkephalins, which are natural pain killers that are released in response to specific potentially painful stimuli. Opiorphin, an opioid peptide, is a potent enkephalin-inactivating zinc ectopeptidases in human inhibitor. Opiorphin inhibits two enkephalin-catabolizing ectoenzymes, human neutral ecto-endopeptidase, hNEP (EC 3.4.24.11) with an IC50 value of 11 μM, and human ecto-aminopeptidase, hAP-N (EC 3.4.11.2). Opiorphin displays potent analgesic activity by activating endogenous opioid-dependent transmission[1][2].
beta-Casomorphin-7
5-[(3S,8R,10R,13R,14S,17R)-3-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,6,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one
[(2R,3R,4S,5S,6R)-3-acetyloxy-2-(acetyloxymethyl)-5-hexanoyloxy-6-[(2S,3R)-2,3,4-trihydroxybutoxy]oxan-4-yl] 14-hydroxytetradecanoate
jaspamide P
A cyclodepsipeptide isolated from Jaspis splendens. A derivative of jaspamide, it has been shown to exhibit cytotoxic and microfilament disruption activity.
16beta-acetoxy-3-O-beta-D-xylopyranosyl-22,25-epoxyholosta-9(11)-ene-3beta,12alpha,17alpha-triol|nobiliside C
Scillirubrosidin 3-O-??-L-rhamnopyranosyl-(1鈥樏傗垎4)-??-L-rhamnopyranoside
Medicagenic acid 3-O-beta-D-glucoside dimethyl ester
3,23-(2-hydroxyethylidene)-3beta,19alpha,23-trihydroxyurs-12-en-28-oic acid 28-O-beta-D-glucopyranosyl ester|oblonganoside J
(18R)-18-O-beta-D-glucopyranosyl-(1-2)-beta-D-glucopyranoside of allo-murolic acid
25-(acetyloxy)-2-(beta-D-glucopyranosyloxy)-3,16-dihydroxy-9-methyl-19-norlanosta-5,23-dien-22-one
(18S)-18-O-beta-D-glucopyranosyl-(1-6)-beta-D-glucopyranoside of protoconstipatic acid
(18R)-18-O-beta-D-glucopyranosyl-(1-3)-beta-D-glucopyranoside of murolic acid
3-O-(alpha-rhamnopyranosyl-(1--4)-beta-O-glucopyranosyl-(1--4)-beta-O-glucopyranosyl)-rishitin|3-O--rishitin
19-[(1S,4R)-4-hydroxy-1-methoxy-2-oxopentyl]-4,5-dihydrogeldanamycin
2alpha,3beta,19alpha-trihydroxyurs-12-en-28-oic acid 28-O-6-O-acetyl-beta-D-glucopyranosyl ester|potentillanoside C
16,17-didehydro-23R,24R-O-acetylhydroshengmanol-3-O-beta-D-galactopyranoside
2alpha-acetoxyl-3beta,6beta-dihydroxylup-20(29)-en-28-oic acid beta-glucopyranosyl ester
3-O-beta-D-glucopyranosylplatycogenic acid A lactone methyl ester
3alpha-Methacryloyloxy-2beta-hydroxy-ent-labd-7-en-15-oic acid-2-O-beta-fucopyranoside methyl ester triacetate
24-O-acetyl-25-O-methyl-7,8-didehydrohydroshengmanol 3-O-beta-D-xylopyranoside
(3beta,5alpha,6beta,8beta,15alpha,16beta)-3-O-[2,4-Di-O-methyl-beta-D-xylopyranoside],15-sulfate,Cholestane-3,6,8,15,16-pentol
3,3,5,8-Tetramethyl-3,3-bis(4-methyl-3-pentenyl)-9,9-dihydroxy-3,3,11,11-tetrahydro-8,10-bi[pyrano[3,2-a]carbazole]
3-dodecanoyl-3-(2-methylbutanoyl)-4-(3-methylbutanoyl)sucrose
5-[(3S,8R,10R,13R,14S,17R)-3-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,6,7,8,9,11,12,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pyran-2-one
[(2R,3R,4S,5S,6R)-3-acetyloxy-2-(acetyloxymethyl)-5-hexanoyloxy-6-[(2S,3R)-2,3,4-trihydroxybutoxy]oxan-4-yl] 14-hydroxytetradecanoate
Monensin sodium salt
Monensin sodium salt is an antibiotic secreted by the bacteria Streptomyces cinnamonensis. Monensin sodium salt is an ionophore that mediates Na+/H+ exchange. Monensin sodium salt causes a marked enlargement of the multivesicular bodies (MVBs) and regulates exosome secretion[1][2][3][4].
Pisumoside B
Bismahanine
Transvaalin
Echinasteroside C 15-O-sulfate
N,N-(methylenedi-p-phenylene)bis[N-[3-(triethoxysilyl)propyl]urea]
(16alpha,20R,22S,23S)-16,23:22,25-diepoxy-2,20,22,23-tetrahydroxycucurbita-1,5-diene-3,11-dione 2-O-beta-D-glucopyranoside
A triterpenoid saponin of the class of cucurbitane glycosides isolated from the roots of Machilus yaoshansis. It has been shown to exhibit inhibitory activity against protein tyrosine phosphatase.
Monensin Sodium
D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D000890 - Anti-Infective Agents > D000935 - Antifungal Agents D004791 - Enzyme Inhibitors > D014475 - Uncoupling Agents D007476 - Ionophores > D061209 - Proton Ionophores D007476 - Ionophores > D061210 - Sodium Ionophores D049990 - Membrane Transport Modulators Monensin sodium salt is an antibiotic secreted by the bacteria Streptomyces cinnamonensis. Monensin sodium salt is an ionophore that mediates Na+/H+ exchange. Monensin sodium salt causes a marked enlargement of the multivesicular bodies (MVBs) and regulates exosome secretion[1][2][3][4].
3-Lauryl-3-(2-methylbutanoyl)-4-(isovaleryl)sucrose
Sucrose-2-(2-methyl)butyryl-4-(2-methyl)butyryl-3-(4-methyl)hexanoyl-6-isobutyrate
(2R)-2-[[(2S)-2-[[(2R)-2-[(3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoyl]amino]propanoyl]amino]-5-[[(2S)-6-amino-1-[[(1R)-1-carboxyethyl]amino]-1-oxohexan-2-yl]amino]-5-oxopentanoic acid
[(3S,6R,8S,9R,10R,13R,14S,15R,16R,17R)-3-[(2S,3S,5R)-4,5-dihydroxy-3-methoxyoxan-2-yl]oxy-6,8,16-trihydroxy-17-[(2R,6S)-7-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-1,2,3,6,7,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-15-yl] hydrogen sulfate
2-[[(2R)-2-[(E)-7-carboxy-5-hydroxyhept-6-enoyl]oxy-3-[(Z)-octadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoxy]propan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
[1-acetyloxy-3-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate
[1-hexanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
[1-butanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate
[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-octanoyloxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
[1-acetyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate
[1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate
Opiorphin
Opiorphin, an opioid peptide, is a potent enkephalin-inactivating zinc ectopeptidases in human inhibitor. Opiorphin inhibits two enkephalin-catabolizing ectoenzymes, human neutral ecto-endopeptidase, hNEP (EC 3.4.24.11) with an IC50 value of 11 μM, and human ecto-aminopeptidase, hAP-N (EC 3.4.11.2). Opiorphin displays potent analgesic activity by activating endogenous opioid-dependent transmission[1][2].
(2s,3s)-2-[(14r)-14-{[4,5-dihydroxy-6-(hydroxymethyl)-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}pentadecyl]-4-methylidene-5-oxooxolane-3-carboxylic acid
5-[(1r,3ar,3bs,7s,9ar,9br,11ar)-7-{[(2r,3r,4s,5r,6s)-3,4-dihydroxy-6-methyl-5-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-3a,3b-dihydroxy-9a,11a-dimethyl-1h,2h,3h,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]pyran-2-one
[(4ar,5r,6as,6br,8ar,10s,12ar,12br,14bs)-5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-10-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carbonyloxy]acetic acid
(6r)-6-[(1e,3r,5e,7e,9s,11r,12s,13s)-12-{[(2r,3s,4r,5s,6r)-5-{[(2r,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-3,7,9,11,13-pentamethyl-10-oxohexadeca-1,5,7-trien-1-yl]-5,6-dihydropyran-2-one
(1s,3r,6r,8r,12s,13r,15r,16r,17r)-15-[(2r,5r)-5,6-dihydroxy-6-methyl-4-oxoheptan-2-yl]-13-hydroxy-7,7,12,16-tetramethyl-14-oxo-6-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadec-10-en-17-yl acetate
(6s,6ar,10as,14r)-12-hexanoyl-10a,13-dihydroxy-6-isopropyl-2,2,4,4,8,8,10,10-octamethyl-14-(2-methylpropyl)-6a,14-dihydro-6h-5,11-dioxapentaphene-1,3,7,9-tetrone
(1r,2r,3r,3ar,4s,5ar,6s,7s,8s,10ar,10bs)-8-(acetyloxy)-3,4,6-tris(butanoyloxy)-7-hydroxy-1-isopropyl-3a,5a,9-trimethyl-1h,2h,3h,4h,5h,6h,7h,8h,10ah,10bh-cyclohepta[e]inden-2-yl butanoate
(2r,3s)-3-methyl-1-{[(2r,3s)-3-methyl-1-{[(2r,3s)-3-methyl-1-{[(2r,3s)-3-methyl-1-oxo-1-[(2r,3s)-2,3,4-trihydroxybutoxy]pentan-2-yl]oxy}-1-oxopentan-2-yl]oxy}-1-oxopentan-2-yl]oxy}-1-oxopentan-2-yl (2r,3s)-2-hydroxy-3-methylpentanoate
2-{[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-3,5-bis[(2-methylbutanoyl)oxy]-6-{[(2-methylbutanoyl)oxy]methyl}oxan-4-yl hexanoate
4,8a-dimethyl 2-hydroxy-4,6a,6b,11,11,14b-hexamethyl-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4,8a-dicarboxylate
methyl (1s,12r,14s,15e,18s)-15-ethylidene-12-[(1r,15s,17s,18r)-17-[(1s)-1-hydroxyethyl]-6-methoxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]nonadeca-2(10),4,6,8-tetraen-5-yl]-18-(hydroxymethyl)-17-methyl-10,17-diazatetracyclo[12.3.1.0³,¹¹.0⁴,⁹]octadeca-3(11),4,6,8-tetraene-18-carboxylate
2-{[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-3-[(2-methylbutanoyl)oxy]-5-[(3-methylbutanoyl)oxy]-6-{[(2-methylbutanoyl)oxy]methyl}oxan-4-yl hexanoate
6-[12-({5-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-3,4-dihydroxy-6-methyloxan-2-yl}oxy)-3,7,9,11,13-pentamethyl-10-oxohexadeca-1,5,7-trien-1-yl]-5,6-dihydropyran-2-one
(6r)-6-[(1e,3s,5e,7e,9r,11s,12r,13s)-12-{[(2r,3r,4s,5r,6r)-5-{[(2s,4s,5s,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-3,4-dihydroxy-6-methyloxan-2-yl]oxy}-3,7,9,11,13-pentamethyl-10-oxohexadeca-1,5,7-trien-1-yl]-5,6-dihydropyran-2-one
4,8a-dimethyl (2s,3r,4s,4ar,6ar,6bs,8as,12as,14ar,14br)-2-hydroxy-4,6a,6b,11,11,14b-hexamethyl-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4,8a-dicarboxylate
(1r,2r,3r,3ar,4s,5ar,6s,7s,8s,10as,10br)-8-(acetyloxy)-3,4,6-tris(butanoyloxy)-7-hydroxy-1-isopropyl-3a,5a,9-trimethyl-1h,2h,3h,4h,5h,6h,7h,8h,10ah,10bh-cyclohepta[e]inden-2-yl butanoate
15-(5,6-dihydroxy-6-methyl-4-oxoheptan-2-yl)-13-hydroxy-7,7,12,16-tetramethyl-14-oxo-6-[(3,4,5-trihydroxyoxan-2-yl)oxy]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadec-10-en-17-yl acetate
(1s,2s,10r,11r,14r,15r,16r,17s,21s,23r)-16,17,21-trihydroxy-1,6,6,11,14,16,19,19-octamethyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-18,22-dioxahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁵,²³.0¹⁷,²¹]tetracosa-4,8-diene-7,12-dione
1-{10,11-dihydroxy-4,6,12,17,17-pentamethyl-18-[(3,4,5-trihydroxyoxan-2-yl)oxy]-9-oxahexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docos-13-en-8-yl}-2-methoxy-2-methylpropyl acetate
3-O-(6-O-methyl-β-D-glucuronopyranosyl)methyl asiatate
{"Ingredient_id": "HBIN009015","Ingredient_name": "3-O-(6-O-methyl-\u03b2-D-glucuronopyranosyl)methyl asiatate","Alias": "NA","Ingredient_formula": "C38H60O11","Ingredient_Smile": "NA","Ingredient_weight": "692.88","OB_score": "20.33901891","CAS_id": "140366-50-3","SymMap_id": "SMIT03061","TCMID_id": "NA","TCMSP_id": "MOL000462","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}